Resultats de la cerca - David M. Nathan

Refinar resultats
  1. 1
    Rosiglitazone and Cardiotoxicity — Weighing the Evidence

    Rosiglitazone and Cardiotoxicity — Weighing the Evidence per David M. Nathan

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  2. 2
    International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes

    International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes per David M. Nathan

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview

    The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview per David M. Nathan

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Realising the long-term promise of insulin therapy: the DCCT/EDIC study

    Realising the long-term promise of insulin therapy: the DCCT/EDIC study per David M. Nathan

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Associati... per David M. Nathan

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Implications of the Diabetes Prevention Program and Look AHEAD Clinical Trials for Lifestyle Interventions

    Implications of the Diabetes Prevention Program and Look AHEAD Clinical Trials for Lifestyle Interventions per Linda M. Delahanty, David M. Nathan

    Publicat 2008
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC)

    Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of... per John M. Lachin, David M. Nathan

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    Relationship between glycated haemoglobin levels and mean glucose levels over time

    Relationship between glycated haemoglobin levels and mean glucose levels over time per David M. Nathan, Heather Turgeon, Susan Regan

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Empirically Establishing Blood Glucose Targets to Achieve HbA1c Goals

    Empirically Establishing Blood Glucose Targets to Achieve HbA1c Goals per Nancy Wei, Hui Zheng, David M. Nathan

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Insulin Sensitivity during Combined Androgen Blockade for Prostate Cancer

    Insulin Sensitivity during Combined Androgen Blockade for Prostate Cancer per Matthew R. Smith, Hang Lee, David M. Nathan

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Clinical Predictors of Disease Progression and Medication Initiation in Untreated Patients With Type 2 Diabetes and A1C Less Than 7%

    Clinical Predictors of Disease Progression and Medication Initiation in Untreated Patients With Type 2 Diabetes and A1C Less Than 7% per Lydie Pani, David M. Nathan, Richard W. Grant

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring

    Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring per Roy Malka, David M. Nathan, John M. Higgins

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes

    The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes per John M. Lachin, Ionut Bebu, David M. Nathan

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Psychological Predictors of Physical Activity in the Diabetes Prevention Program

    Psychological Predictors of Physical Activity in the Diabetes Prevention Program per Linda M. Delahanty, Molly B. Conroy, David M. Nathan

    Publicat 2006
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study

    Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study per John M. Lachin, Trevor J. Orchard, David M. Nathan

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Adipocytokines, Obesity, and Insulin Resistance During Combined Androgen Blockade for Prostate Cancer

    Adipocytokines, Obesity, and Insulin Resistance During Combined Androgen Blockade for Prostate Cancer per Matthew Smith, Hang Lee, Mary Anne Fallon, David M. Nathan

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    The Hemoglobin Glycation Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control and Complications Trial

    The Hemoglobin Glycation Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control and Complications Trial per John M. Lachin, Saul Genuth, David M. Nathan, Brandy Rutledge

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Value of Risk Stratification to Increase the Predictive Validity of HbA1c in Screening for Undiagnosed Diabetes in the US Population

    Value of Risk Stratification to Increase the Predictive Validity of HbA1c in Screening for Undiagnosed Diabetes in the US Population per Adit A. Ginde, Enrico Cagliero, David M. Nathan, Carlos A. Camargo

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Intensification of diabetes medication and risk for 30‐day readmission

    Intensification of diabetes medication and risk for 30‐day readmission per Nancy Wei, Deborah J. Wexler, David M. Nathan, Richard W. Grant

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Management of hyperglycaemia in type 2 diabetes: the end of recurrent failure?

    Management of hyperglycaemia in type 2 diabetes: the end of recurrent failure? per R.J. Heine, M. Diamant, Jean Claude Mbanya, David M. Nathan

    Publicat 2006
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:

Eines de cerca: